Walter Desmet1*, MD, PhD; Adel Aminian2, MD; Joëlle Kefer3, MD, PhD; Joseph Dens4, MD, PhD; Johan Bosmans5, MD, PhD; Marc Claeys5, MD, PhD; Christophe Dubois1, MD, PhD; Olivier Gach6, MD, PhD; Luc Janssens7, MD; Erwin Schroeder8, MD, PhD; Paul Vermeersch9, MD, PhD; Marc Carlier10, MD; Edouard Benit11, MD; Claude Hanet8, MD, PhD; on behalf of the Belgian Working Group of Interventional Cardiology (BWGIC)
1. Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium, and Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium; 2. Division of Cardiology, Centre Hospitalier Universitaire de Charleroi, C
In a ranking of the gross domestic product per capita in 2015, Belgium ranked 19th in the world according to the International Monetary Fund and the World Bank. It has a Human Development Index of 0.890, in which it is preced